The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients

被引：0
|
作者：
Bonigliere, L. [1 ]
Torrisi, R. [1 ]
Pruneri, G. [1 ]
Colleoni, M. [1 ]
Viale, G. [1 ]
机构：
[1] European Inst Oncol, Milan, Italy
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
97
引用
收藏
页码：24A / 24A
页数：1
相关论文
共 50 条
  • [21] HER2 up-regulation with neoadjuvant endocrine therapy in patients with hormone receptor-positive, HER2-negative breast cancer
    Chaudhary, Lubna N.
    Jorns, Julie
    Gonyo, MaryBeth
    Kong, Amanda
    Peck, Amy R.
    Sun, Yunguang
    Bergom, Carmen
    Banarjee, Anjishnu
    Chitambar, Christopher
    Rui, Hallgeir
    CANCER RESEARCH, 2020, 80 (04)
  • [22] Her2 Status Following Neoadjuvant Trastuzumab Therapy for Primary Breast Cancer
    Sanders, M. A. G.
    Richardson, A. L.
    Ly, A.
    MODERN PATHOLOGY, 2011, 24 : 62A - 62A
  • [23] Her2 Status Following Neoadjuvant Trastuzumab Therapy for Primary Breast Cancer
    Sanders, M. A. G.
    Richardson, A. L.
    Ly, A.
    LABORATORY INVESTIGATION, 2011, 91 : 62A - 62A
  • [24] Influence of Neoadjuvant Chemotherapy on HER2/neu Status in Invasive Breast Cancer
    Li, Peifeng
    Liu, Tantan
    Wang, Yingmei
    Shao, Shuai
    Zhang, Weichen
    Lv, Yang
    Yi, Jun
    Wang, Zhe
    CLINICAL BREAST CANCER, 2013, 13 (01) : 53 - 60
  • [25] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    MODERN PATHOLOGY, 2018, 31 : 54 - 54
  • [26] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    LABORATORY INVESTIGATION, 2018, 98 : 54 - 54
  • [27] Does hormone receptor status influence survival in HER2/neu positive breast cancer?
    Spellman, A.
    McDermott, A. M.
    Wall, D.
    Keane, M.
    Donnellan, P.
    Sweeney, K. J.
    Kerin, M. J.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 6 - 6
  • [28] Conversion of ER and HER2 Status After Neoadjuvant Therapy in Chinese Breast Cancer Patients
    Bo, Jiaqi
    Yu, Baohua
    Bi, Rui
    Xu, Xiaoli
    Cheng, Yufan
    Tu, Xi aoyu
    Bai, Qianming
    Yang, Wentao
    Shui, Ruohong
    CLINICAL BREAST CANCER, 2023, 23 (04) : 436 - 446
  • [29] Hormone receptor status might be a determinant for HER2 loss after HER2-targeted treatment in HER2 positive breast cancer patients
    Altundag, Kadri
    JOURNAL OF BUON, 2019, 24 (05): : 2206 - 2206
  • [30] Change of HER2 status following neoadjuvant systemic therapy in primary breast cancer patients
    Yoshida, Atsushi
    Hayashi, Naoki
    Yagata, Hiroshi
    Suzuki, Koyu
    Nakamura, Seigo
    Yamauchi, Hideko
    CANCER RESEARCH, 2015, 75
12345